Biomarkers and diagnostic tools for lung cancer

Lung cancer is the leading cause of cancer-related deaths in developing to advanced countries worldwide. The incidence rate lung Korea has been increasing steadily since 1997. Statistics show that 2017 alone, and mortality rates for were 52.7 34.8 per 100,000 people, respectively, accounting highest death Korea. process accurately diagnosing consists several steps, starting with discovery pulmonary nodule(s) via a screening test or various other methods followed by collection cells tissues identification target molecules. Thereafter, staging development therapeutic plan lead improved clinical outcomes. After completion pilot study, nationwide program was introduced Korea; 2019, this targeted population at high risk cancer: men women aged 54 74 years who had smoking history 30 pack-years more. frequency detection nodules proportion public interest health economic growth. In review, we present diagnostic techniques biomarkers are widely used medical field hope such information would benefit practice.